Newsroom

NIH has announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component needed to return to normal during this unprecedented global pandemic.

A team at ClearCam, Inc., with funding from the NIBIB and ties to the University of Texas at Austin, designed a device for wiping a laparoscope lens clean, much the same way that a wiper blade clears a fogged up window.

Marking a major milestone on the path to meeting the objectives of the NIH BRAIN initiative, researchers advance high-density electroencephalography (EEG) as the future paradigm for dynamic functional neuroimaging.

Medical physicists at the Mayo Clinic have just made a unique library of computed tomography (CT) data publicly available so that imaging researchers can study, develop, validate, and optimize algorithms and enhance imaging hardware to produce peak-quality CT images using low radiation doses.

In this interview, David Zierler, Oral Historian for AIP, interviews Richard Leapman, Senior Investigator in the National Institute for Biomedical Imaging and Bioengineering and Scientific Director of the intramural program. Leapman recounts his childhood in England and he describes his early and formative experience playing with an optical microscope. Source: American Institute of Physics

Researchers at the University of Memphis-based Center of Excellence for Mobile Sensor Data-to-Knowledge (MD2K) have introduced a new mobile app that may support physical distancing during the COVID-19 pandemic. MD2K is supported by NIH with a grant administered by the NIBIB.

A new study has begun recruiting at the National Institutes of Health in Bethesda, Maryland, to determine how many adults in the United States without a confirmed history of infection with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), have antibodies to the virus.

Bioengineers have created a blood-drawing robot that performed as well or better than technicians. The device could increase blood draw success from difficult- to-find veins and allow healthcare workers more time to treat patients.

Bioengineers have combined standard microscopy, infrared light, and artificial intelligence to assemble digital biopsies that identify important molecular characteristics of cancer biopsy samples.